Stockreport

Annovis Bio Announces Update on Phase II Clinical Trial for Alzheimer’s Disease

Annovis Bio, Inc.  (ANVS) 
PDF BERWYN, Pa., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s, Parkinson’s and o [Read more]